Evaluation of a Human BCG Challenge Model to Assess Antimycobacterial Immunity Induced by BCG and a Candidate Tuberculosis Vaccine, MVA85A, Alone and in Combination
Author(s) -
S. Harris,
Joel N. Meyer,
Iman Satti,
Leanne Marsay,
Ian Poulton,
Richard Tanner,
Angela M. Minassian,
Helen A. Fletcher,
Helen McShane
Publication year - 2013
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jit647
Subject(s) - antimycobacterial , bcg vaccine , tuberculosis , tuberculosis vaccines , immunology , immunity , vaccination , medicine , mycobacterium tuberculosis , virology , immune system , pathology
A new vaccine is urgently needed to combat tuberculosis. However, without a correlate of protection, selection of the vaccines to take forward into large-scale efficacy trials is difficult. Use of bacille Calmette-Guérin (BCG) as a surrogate for human Mycobacterium tuberculosis challenge is a novel model that could aid selection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom